Therapeutic validity and effectiveness of guideline-recommended medical therapy in acute heart failure patients on regular hemodialysis

25 August 2018 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Doctor Keiko Mizobuchi

Tokyo Women's Medical University, Tokyo (Japan)

11 More presentations in this session

Presentation thumbnail

Cell growth, survival, and differentiation signal transduction pathways in advanced failing myocardium (gender dependent differences).

Professor P. Leszek (Warsaw, PL)

Abstract Slides

Presentation thumbnail

Accumulating evidence for deleterious effects of digoxin in heart failure and atrial fibrillation: an updated meta-analysis

Associate Professor M. Vamos (Szeged, HU)

Abstract Slides

Presentation thumbnail

Effect of cardiovascular risk factors on left ventricular ejection fraction in HER2 positive breast cancer patients who were treated in adjuvant setting with trastuzumab

Professor M. Deljanin Ilic (Niska Banja, RS)

Abstract Slides

Presentation thumbnail

Cardioprotective potential of an SGLT2 inhibitor against doxorubicin-induced heart failure

Assistant Professor S. Cho (Seoul, KR)

Presentation thumbnail

Sympathomimetic beta-1AR autoantibodies in patients after heart transplantation are associated with higher mitochondrial coupling efficiency

Doctor J. Haschemi (Duesseldorf, DE)

Abstract Slides

Access the full session

Session thumbnail

Poster Session 3 - Chronic heart failure – Pathophysiology and mechanisms

The Event

ESC Congress 2018

25 August - 29 August 2018

You may be interested in

Congress Presentation

Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.

Congress Session

Chronic kidney disease and heart failure

Congress Session

Rare causes of heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources